The Hispanic population will grow to represent nearly one-third of residents in the USA by mid-century. A new AHA Science Advisory paper provides an overview of current evidence on cardiovascular disease in this population, including prevailing risk factors and specific clinical approaches for treatment, and predicts what insights future research might reveal.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rodriguez, C. J. et al. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States. Circulation http://dx.doi.org/10.1161/CIR.0000000000000071.
Easley, J. Obama to Hispanics: we won't deport relatives because you enroll in ObamaCare. The Hill (Washington DC) (18 Mar 2014).
Dawber, T. R. et al. Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study. Am. J. Public Health Nations Health 49, 1349–1356 (1959).
Stone, N. J. et al. 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 63, 2889–2934 (2014).
Daviglus, M. L. et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA 308, 1775–1784 (2012).
Rose, G. Sick individuals and sick populations. Int. J. Epidemiol. 30, 427–432 (2001).
US Department of Agriculture Economic Research Service. The U.S. grain consumption landscape: who eats grain, in what form, where and how much [online], (2007).
The SIGMA Type 2 Diabetes Consortium. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 506, 97–101 (2014).
Kahn, J. Mandating race: how the USPTO is forcing race into biotech patents. Nat. Biotechnol. 29, 401 (2011).
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A., Haynes, R. B. & Richardson, W. S. Evidence based medicine: what it is and what it isn't. BMJ 312, 71 (1996).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Kaplan, R. An agenda to promote Hispanic cardiovascular health. Nat Rev Cardiol 11, 560–562 (2014). https://doi.org/10.1038/nrcardio.2014.126
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2014.126
